Literature DB >> 11049006

Driving under light and dark conditions: effects of alcohol and diazepam in young and older subjects.

J Vanakoski1, M J Mattila, T Seppälä.   

Abstract

OBJECTIVES: Driving at night time increases accident risk due to visual conditions, fatigue and impaired performance. In addition, the use of alcohol and benzodiazepines may enhance the risks related to night-time driving. We studied these aspects of traffic safety in a simulated driving test with young and older drivers.
METHODS: In a double-blind, crossover, placebo-controlled study, nine young subjects, aged 22-24 years, performed simulated driving in both 'light' and 'dark' conditions, before and 1.5 h and 4 h after 0.8 g x kg(-1) ethanol (EOH) or 15 mg diazepam (DZ). Further, nine older subjects, aged 55-77 years, were similarly tested, but their EOH dose was 0.7 g x kg(-1) and the DZ dose was 10 mg. The tests were vigilance assessment on visual analogue scales (VAS), simulated driving under light and dark conditions for 6 min each and digit symbol substitution (DSS).
RESULTS: In the young subjects, both EOH and DZ similarly impaired DSS, with DZ causing more subjective drowsiness, clumsiness, mental slowness and poor overall performance than EOH. During simulated driving, both EOH and DZ impaired simple and complex tracking (EOH > DZ) and prolonged reaction times (EOH = DZ). Impairment of performance was practically identical under light and dark conditions. In the older subjects, objective performance on DSS was poorer (-30%) than that of the young ones, and subjective impairment was marginal. During simulated driving, the baseline levels of variables in older subjects showed definite impairment (errors +100% to +500%) when compared with young subjects. Active drugs impaired several variables (EOH > DZ), but the statistical significances were fewer than in young subjects. Increase in reaction errors reached statistical significance, especially while driving in the dark. Otherwise the driving results in light and dark were not notably different.
CONCLUSION: Young subjects drew good baselines but were sensitive to EOH and DZ, whilst the older subjects showed poor baselines but were less sensitive to EOH and DZ. Although the baseline driving and responses to treatments were different in young and older subjects, their driving and psychomotor impairment were unaffected by light conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11049006     DOI: 10.1007/s002280000167

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  The additive effects of alcohol and benzodiazepines on driving.

Authors:  Hillary G Maxwell; Sacha Dubois; Bruce Weaver; Michel Bédard
Journal:  Can J Public Health       Date:  2010 Sep-Oct

Review 2.  Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence.

Authors:  Tharaka Dassanayake; Patricia Michie; Gregory Carter; Alison Jones
Journal:  Drug Saf       Date:  2011-02-01       Impact factor: 5.606

Review 3.  Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review.

Authors:  Toni M Rudisill; Motao Zhu; George A Kelley; Courtney Pilkerton; Brandon R Rudisill
Journal:  Accid Anal Prev       Date:  2016-08-29

Review 4.  Impact of psychotropic medications on simulated driving: a critical review.

Authors:  Mark J Rapoport; Melanie C Baniña
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

5.  The role of marital status in the association between benzodiazepines, psychotropics and injurious road traffic crashes: a register-based nationwide study of senior drivers in Sweden.

Authors:  Kristina Johnell; Lucie Laflamme; Jette Möller; Joel Monárrez-Espino
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

6.  Concurrent Use of Benzodiazepines and Antidepressants and the Risk of Motor Vehicle Accident in Older Drivers: A Nested Case-Control Study.

Authors:  Jean-Pascal Fournier; Machelle Wilchesky; Valérie Patenaude; Samy Suissa
Journal:  Neurol Ther       Date:  2015-03-06

7.  Behavioral and Neurophysiological Signatures of Benzodiazepine-Related Driving Impairments.

Authors:  Bradly T Stone; Kelly A Correa; Timothy L Brown; Andrew L Spurgin; Maja Stikic; Robin R Johnson; Chris Berka
Journal:  Front Psychol       Date:  2015-11-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.